PDT Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $112K | Hold |
|
|||||
|
2024
Q2 | $168K | Buy |
|
|||||
|
2024
Q1 | $142K | Buy |
|
|||||
|
2023
Q4 | – | Sell |
|
|||||
|
2023
Q3 | $311K | Buy |
|
|||||
|
2020
Q1 | – | Sell |
|
|||||
|
2019
Q4 | $2.21M | Sell |
|
|||||
|
2019
Q3 | $3.06M | Sell |
|
|||||
|
2019
Q2 | $3.07M | Sell |
|
|||||
|
2019
Q1 | $2.78M | Buy |
|
|||||
|
2018
Q4 | $1.78M | Sell |
|
|||||
|
2018
Q3 | $5.03M | Sell |
|
|||||
|
2018
Q2 | $6.36M | Buy |
|
|||||
|
2018
Q1 | $4.41M | Sell |
|
|||||
|
2017
Q4 | $5.65M | Buy |
|
|||||
|
2016
Q1 | – | Sell |
|
|||||
|
2015
Q4 | $1.7M | Sell |
|
|||||
|
2015
Q3 | $2.68M | Buy |
|
|||||
|
2015
Q2 | $2.14M | Buy |
|
|||||
|
2015
Q1 | $1.03M | Buy |
|